Back
Actuate Therapeutics, Inc. 10K Form
Sell
6
ACTU
Actuate Therapeutics, Inc.
Last Price:
$3.84
Seasonality Move:
37.94%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ACTU News And Ratings
See the #1 stock for the next 7 days that we like better than ACTU
ACTU Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-6.5M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.47 |
| Price / Book: | 7.95 |
Profitability
| EPS (TTM): | -1.20950 |
|---|---|
| Net Income (TTM): | $-24.1M |
| Gross Margin: | $0 |
| Return on Equity: | -1392.96% |
| Return on Assets: | -228.64% |
Actuate Therapeutics, Inc. Earnings Forecast
Key Actuate Therapeutics, Inc. Financial Ratios
-
Per Share Earnings over the last 3 years have been positive in 0 years.
Actuate Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ACTU |
| Website: | actuatetherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0.04 |
|---|---|
| Current Ratio: | 2.74 |
| Quick Ratio: | 2.66 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ACTU Technical Analysis vs Fundamental Analysis
Sell
6
Actuate Therapeutics, Inc. (ACTU)
is a Sell
Is Actuate Therapeutics, Inc. a Buy or a Sell?
-
Actuate Therapeutics, Inc. stock is rated a SellThe current Actuate Therapeutics, Inc. [ACTU] share price is $3.74. The Score for ACTU is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.